ARCHIVES

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

New Source of Research Funds? As Clinton Derails Tobacco Deal, Prospects May Brighten for Tougher Measures In ‘98

September 19, 1997

Funding Opportunities.

March 22, 2002

In Brief: UCSD Recruits Mitchell From USC; Wade Wins Policy Fellowship; ASCO Honors Burchenal

July 15, 1994

Mayo’s Regional Program – Keys To Success Are Service, Communications

December 9, 1977

Rumors Preceded Broder’s Move

December 22, 1994

NCI To Ask HCFA to Launch Pilot Clinical Trials Program

March 22, 1996